SCHEMBL6938450

SCHEMBL6938450

O=C(O)CCCCC1C(CCCCC(=O)O)C(CCCCC(=O)O)C(CCCCC(=O)O)C(CCCCC(=O)O)C1CCCCC(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.65
TSHR P16473 5/20 0.61
NFKB1 P19838 2/20 0.61
PMP22 Q01453 1/20 0.61
SLC22A6 Q4U2R8 2/20 0.56
GPR84 Q9NQS5 5/20 0.50
FFAR1 O14842 2/20 0.50
FFAR4 Q5NUL3 2/20 0.50
AKR1B1 P15121 1/20 0.50
CYP2D6 P10635 1/20 0.50
FOLH1 Q04609 1/20 0.50
PPARG P37231 6/20 0.48
PPARD Q03181 6/20 0.48
PPARA Q07869 6/20 0.48
HDAC11 Q96DB2 5/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
PTPN1 P18031 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adipic Acid SCHEMBL9092384 0.80 LMNA (1.00) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL28191616 0.80 LMNA (1.00) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL4930 0.80 LMNA (1.00) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL1330953 0.80 LMNA (1.00) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL25482 0.80 LMNA (1.00) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL28337915 0.80 LMNA (1.00) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL28191617 0.80 LMNA (1.00) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL8941691 0.80 LMNA (1.00) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL2244299 0.80 LMNA (1.00) LMNATSHRNFKB1PMP22SLC22A6
Adipic Acid SCHEMBL8407905 0.80 LMNA (1.00) LMNATSHRNFKB1PMP22SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642383-B2 Of the class 3,3,5,5-tetramethyl-2-oxo-1,4-piperazine, polymers thereof; stabilizers for thermoplastic organic polymers, coating compositions or photographic materials CIBA SPECIALTY CHEMICALS CORPORATION 2003-11-04 US disclosed
US-20020115859-A1 Oxopiperazinyl derivatives and light stabilized compositions LAZZARI DARIO (IT) 2002-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115859-A1 Oxopiperazinyl derivatives and light stabilized compositions CBR1, PYM1, CCT4 LMNA 649/4885TSHR 4651/4885NFKB1 2664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.